Gissoo DeCotiis is a dynamic leader in global patient advocacy and professional relations, with a proven track record of driving patient-centric strategies and building impactful alliances across the pharmaceutical and healthcare industries. With extensive experience in managing large, complex projects and engaging diverse stakeholders, Gissoo excels at fostering collaboration and innovation to advance patient care across therapeutic areas.
While serving as Global Head of Advocacy and Professional Relations, Oncology at Daiichi Sankyo, Gissoo has developed and implemented global engagement strategies, established best-in-class advocacy centers of excellence, and led collaborations with over 600 patient advocacy groups and professional organizations worldwide. Her passion for cancer patients has championed the patient voice in clinical trials, public policy, and advisory boards, ensuring that patient perspectives are integrated throughout the lifecycle of medical compounds.
Previously, at Bayer Healthcare Pharmaceuticals, Gissoo redefined the role of advocacy within the organization, elevating Bayer’s reputation among advocacy groups and pioneering initiatives such as Clinical Trial Navigation Services and the inclusion of expert patients in clinical trial steering committees. Their strategic vision and collaborative approach have consistently delivered innovative solutions and measurable improvements in patient engagement and organizational culture.
With earlier roles at American Express, Gissoo brings a broad business acumen, having managed multi-million-dollar portfolios and spearheaded cross-functional initiatives in competitive intelligence and product development.
A recognized thought leader, Gissoo has contributed to peer-reviewed publications and patient lay summaries, and has received numerous awards for corporate partnership, innovation, and leadership from leading organizations such as CancerCare, NORD, and the American Liver Foundation.
Gissoo Decotiis holds advanced degrees from Rutgers University, and is fluent in English and Farsi, with competency in Spanish and French. Her expertise spans alliance management, strategy development, advocacy, marketing, and business development, underpinned by a commitment to improving patient outcomes and advancing the field of oncology advocacy.